These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2071587)

  • 1. A kinetic model for the alpha-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III.
    Naski MC; Shafer JA
    J Biol Chem; 1991 Jul; 266(20):13003-10. PubMed ID: 2071587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.
    Higgins DL; Lewis SD; Shafer JA
    J Biol Chem; 1983 Aug; 258(15):9276-82. PubMed ID: 6409903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Thrombin within fibrin clots: inactivation of thrombin by antithrombin-III.
    Naski MC; Shafer JA
    Thromb Res; 1993 Mar; 69(5):453-65. PubMed ID: 8497860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin.
    Lewis SD; Shields PP; Shafer JA
    J Biol Chem; 1985 Aug; 260(18):10192-9. PubMed ID: 4019507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thrombin that are critical for heparin and fibrin(ogen) interactions.
    Church FC; Pratt CW; Noyes CM; Kalayanamit T; Sherrill GB; Tobin RB; Meade JB
    J Biol Chem; 1989 Nov; 264(31):18419-25. PubMed ID: 2509458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
    Ng AS; Lewis SD; Shafer JA
    Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
    Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin.
    Naski MC; Shafer JA
    J Biol Chem; 1990 Jan; 265(3):1401-7. PubMed ID: 2295636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors.
    Le Bonniec BF; Guinto ER; MacGillivray RT; Stone SR; Esmon CT
    J Biol Chem; 1993 Sep; 268(25):19055-61. PubMed ID: 8395526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinopeptides A and B release in the process of surface fibrin formation.
    Riedel T; Suttnar J; Brynda E; Houska M; Medved L; Dyr JE
    Blood; 2011 Feb; 117(5):1700-6. PubMed ID: 21106983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors.
    Hofsteenge J; Taguchi H; Stone SR
    Biochem J; 1986 Jul; 237(1):243-51. PubMed ID: 3026312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations.
    Mihalyi E
    Biochemistry; 1988 Feb; 27(3):976-82. PubMed ID: 3365374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interaction of a peptide inhibitor with two forms of monomeric fibrin differing in the degree of activation].
    Chiriat'ev EA; Leonova OP; Byshevskiĭ ASh
    Ukr Biokhim Zh (1978); 1989; 61(1):3-9. PubMed ID: 2741239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates.
    Hogg PJ; Jackson CM
    J Biol Chem; 1990 Jan; 265(1):248-55. PubMed ID: 2294105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-step fibrinogen--fibrin transition in blood coagulation.
    Blombäck B; Hessel B; Hogg D; Therkildsen L
    Nature; 1978 Oct; 275(5680):501-5. PubMed ID: 692730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen.
    Gorkun OV; Veklich YI; Weisel JW; Lord ST
    Blood; 1997 Jun; 89(12):4407-14. PubMed ID: 9192765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.